Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMedical Developments International Ltd

Medical Developments International Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.4 AUD 0.00(0%)
Last update at 2026-11-06T05:10:00Z
VOLUME
48541
Market Cap
45.06M
P/E
40.00

Momentum Score

…

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers, and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.42
High
52 Week Price Range
0.36
Low
0.62
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Medical Developments International Ltd develops, manufactures and distributes Penthrox, an inhaled analgesic used for short-term pain relief in emergency, ambulance and procedural settings. Long-term growth may be supported by geographic expansion, additional regulatory approvals and broader clinical adoption in institutional channels, along with scaling manufacturing and distribution. Investors may find the company attractive because it appears positioned with a differentiated, recurring-revenue product franchise that could benefit from rising adoption in emergency care.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.40
Dividend Yield
-
Revenue TTM
42.57M
Revenue Per Share
0.38
Gross Profit TTM
30.67M
Debt / Equity
0.03
ROE
1.13%
Net Debt
-12.70M
ROCE
1.69%
Diluted EPS TTM
0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 0.50M 0.17M -32.93M -7.49M -15.91M
Net income 0.63M 0.09M -40.99M -5.61M -12.41M
Selling general administrative - 22.14M 32.55M 32.58M 22.21M
Selling and marketing expenses - 3.94M 2.82M 3.83M 2.60M
Gross profit 11.98M 29.43M 24.37M 22.04M 15.63M
Reconciled depreciation - 3.20M 3.39M 3.11M 2.94M
Ebit 1.06M 0.14M -32.84M -0.69M -15.22M
Ebitda 3.74M 1.67M -29.45M 2.42M -10.69M
Depreciation and amortization 2.69M 1.53M 3.39M 3.11M 4.54M
Operating income 1.06M 3.07M -16.87M -17.30M -12.54M
Other operating expenses 41.51M 35.98M 50.02M -20.14M -24.75M
Interest expense 0.07M 0.07M 0.09M 0.10M 0.10M
Tax provision - 0.07M 8.07M -1.88M -3.50M
Interest income - 0.38M 0.40M 0.66M 0.04M
Net interest income - 0.30M 0.32M 0.56M -0.06M
Income tax expense -0.12M 0.07M 8.07M -1.88M -3.50M
Total revenue 42.57M 39.06M 33.15M 32.17M 22.37M
Total operating expenses 10.92M 26.35M 35.41M 42.48M 32.50M
Cost of revenue 30.59M 9.63M 8.78M 10.12M 6.74M
Total other income expense net -0.55M -2.90M -16.06M 12.39M -0.58M
Net income from continuing ops - 0.09M -40.99M -5.61M -12.41M
Net income applicable to common shares - 0.09M -40.99M -5.61M -12.41M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 68.58M 66.40M 63.77M 101.31M 92.22M
Intangible assets 2.83M 18.11M - 34.51M 36.88M
Other current assets 0.58M - 0.56M 0.79M 0.78M
Total liab 12.77M 11.29M 18.04M 20.00M 34.92M
Total stockholder equity 55.81M 55.10M 45.73M 81.31M 57.30M
Deferred long term liab - - - 32.70M 35.12M
Other current liab 0.73M - 0.64M 1.59M 4.88M
Common stock 115.01M - 105.73M 105.73M 76.99M
Capital stock - 115.01M - 105.73M 76.99M
Retained earnings -62.14M -62.77M -62.86M -30.15M -24.55M
Other liab - - - 2.24M 21.98M
Good will 3.81M 3.81M 3.81M 3.81M 3.81M
Other assets - - 0.00M 8.11M 40.74M
Cash 14.37M 17.84M 9.73M 24.66M 20.40M
Cash and equivalents - - - 24.66M 20.40M
Total current liabilities 6.17M 7.82M 9.55M 15.55M 10.48M
Current deferred revenue 0.25M - 0.28M 0.28M 0.08M
Net debt -12.70M - -7.45M -22.10M -17.59M
Short term debt 0.34M - 0.37M 0.35M 0.35M
Short long term debt total 1.67M - 2.29M 2.56M 2.81M
Other stockholder equity - - - -75.58M -52.45M
Property plant equipment - - - 12.12M 11.55M
Total current assets 35.60M 35.54M 26.14M 42.76M 34.37M
Net tangible assets - - - 75.70M 51.74M
Short term investments 7.00M - - - -
Net receivables 6.70M 7.53M 7.07M 8.93M 6.08M
Inventory 6.95M 9.45M 8.77M 8.38M 7.11M
Accounts payable 4.85M 6.49M 8.25M 13.32M 5.17M
Accumulated other comprehensive income 2.94M - 2.86M 5.74M 4.85M
Non currrent assets other 14.60M - 16.04M -17.74M -17.11M
Non current assets total 32.98M 30.86M 37.63M 58.55M 57.85M
Capital lease obligations - 1.99M - 2.56M 2.81M
Long term debt total - - - 2.21M 2.46M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -1.04M -3.17M -7.10M -5.16M
Change to liabilities - - - 2.36M 0.90M
Total cashflows from investing activities -7.79M -1.04M -3.17M -7.67M -5.21M
Net borrowings - - - -0.25M -0.21M
Total cash from financing activities -0.80M 8.68M -0.81M 28.06M 0.14M
Change to operating activities - - - -0.15M -0.02M
Net income 0.63M 0.09M -40.99M -5.61M -12.41M
Change in cash -3.47M 8.10M -14.93M 4.26M -15.88M
Begin period cash flow 17.84M 9.73M 24.66M 20.40M 36.28M
End period cash flow 14.37M 17.84M 9.73M 24.66M 20.40M
Total cash from operating activities 5.75M -0.04M -10.78M -16.50M -10.72M
Issuance of capital stock - 10.01M - 30.00M 0.36M
Depreciation 2.69M 3.20M 3.39M 3.11M 2.94M
Other cashflows from investing activities - -0.60M -2.38M -5.32M -3.96M
Dividends paid - - - 26.38M 0.14M
Change to inventory 2.62M -0.68M -0.39M -1.84M -1.37M
Change to account receivables 1.09M -0.58M 1.86M -2.87M -2.50M
Sale purchase of stock -0.48M -0.30M -0.53M -1.68M -0.00M
Other cashflows from financing activities -0.32M -1.04M -0.27M -0.25M -0.21M
Change to netincome - - - -12.06M 1.68M
Capital expenditures 0.48M 0.44M 3.17M 7.67M 5.21M
Change in working capital 1.63M -1.14M 4.18M -2.50M -3.59M
Stock based compensation - 1.03M - 1.26M 1.03M
Other non cash items 0.81M -3.23M 22.64M -5.38M 9.75M
Free cash flow 5.27M -0.49M -13.95M -24.16M -15.94M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MVP
Medical Developments International Ltd		 -
-%		 0.40 40.00 166.67 1.06 0.79 0.57 7.45
AFP
Aft Pharmaceuticals Ltd		 -
-%		 3.59 29.92 18.18 1.48 4.37 2.05 18.56
VLS
Vita Life Sciences Ltd		 -
-%		 2.70 13.50 42.73 1.52 2.62 1.19 7.17
LGP
Little Green Pharma Ltd		 -
-%		 0.06 - 10.00 0.64 0.60 1.25 19.47
SNT
Syntara Ltd		 -
-%		 0.02 - 20.45 5.10 2.18 6.32 -2.16

Profile*

Medical Developments International Ltd

Medical Developments International Limited provides emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The company also supplies respiratory products, including space chambers, peak flow meters, portable nebulizers, and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.

4 Caribbean Drive, Scoresby, VIC, Australia, 3179

61 3 9547 1888

https://medicaldev.com

Name Title Year Born
Mr. Brent MacGregor Chief Exec. Officer 1964
Ms. Anita James Chief Financial Officer NA
Matthew Cramer Chief of Operations & Supply Chain NA
Ms. Tara Eaton Gen. Counsel & Company Sec. NA
Ms. Greer Lucas Head of People & Culture NA
Dr. Scott Courtney Chief Scientific Officer NA
Wai Ng Chi Head of Regulatory Affairs NA
Wayne Pearce Head of Production NA
Mr. Stefaan Schatteman Head of Europe NA
Mr. Brent MacGregor Chief Executive Officer 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…